[ACT]IVATED AML
January 2026
An [ACT]IVATED patient is informed, empowered, and engaged in their care. Take advantage of health literacy tools and plug into resources that keep you in the know for the latest in acute myeloid leukemias. Stay [ACT]IVATED.
Program topics includes:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Advances in AML Treatment and Research
What AML Mutations Are Associated With Adverse Outcomes?
February 1, 2023
Challenges in Treating TP53-Mutated AML, Hope on the Horizon
February 1, 2023
A Look at Ongoing Acute Myeloid Leukemia Phase III Trials
February 1, 2023
What Does Triplet Therapy in AML Mean for the Future?
February 1, 2023
A Look at Lower Intensity Chemotherapy in Untreated AML
February 1, 2023
A Look at Treatment Strategies for High-Risk AML Patients
February 1, 2023
Why Is the Menin Pathway Important in AML?
February 1, 2023
The Importance of the FLT3 Mutation in AML
February 1, 2023
AML Treatment Approaches Expand for Older and High-Risk Patients
February 1, 2023
Long-Term Effects Acute Myeloid Leukemia Patients Should Know
February 1, 2023
What Does Transfusion Burden Mean in Acute Myeloid Leukemia?
February 1, 2023
What AML Treatment Options Are Available for MRD-Positive Patients?
February 1, 2023
What Is MRD-Positive Acute Myeloid Leukemia?
February 1, 2023
What Is FLT3-Mutated Acute Myeloid Leukemia?
February 1, 2023
What Are the Latest Acute Myeloid Leukemia Therapies?
January 31, 2023
AML Clinical Trials, Access, and Health Disparities
How Newly Diagnosed AML Patients Can Access the Right Targeted Therapies
November 21, 2025
AML Clinical Trial Access: How You Can Overcome Key Barriers to Care
November 21, 2025
How Can We Address Disparities in AML Among Diverse Populations?
February 1, 2023
Bone Marrow Biopsies & Predictors of AML Outcomes
How Can Bone Marrow Biopsies Be Used in AML Care?
March 25, 2024
How Is AML Care Impacted by Bone Marrow Biopsy Results?
March 24, 2024
Patient-Centered Care & Treatment Decisions
Support Systems for AML: What Patients and Care Partners Need to Know
November 21, 2025
Starting AML Treatment: What Patients Should Ask From Day One
November 21, 2025
Do AML Patients Receive Allo or Auto Stem Cell Transplant?
March 25, 2024
How Can AML Patients Benefit From Shared Decision-Making?
March 25, 2024
The Importance of Acute Myeloid Leukemia Patient Empowerment
March 16, 2023
[ACT]IVATED AML Resources
[ACT]IVATED AML Resource Guide IV
November 21, 2025
[ACT]IVATED AML Patient Plan
June 4, 2024
[ACT]IVATED AML Toolkit Checklist
June 4, 2024
[ACT]IVATED AML Resource Guide III en español
May 29, 2024
[ACT]IVATED AML Resource Guide III
May 29, 2024
[ACT]IVATED AML Resource Guide II
April 22, 2024
[ACT]IVATED AML Resource Guide II en español
April 22, 2024
Becoming an Empowered and [ACT]IVATED AML Patient
March 14, 2023
[ACT]IVATED AML Resource Guide en español
March 1, 2023
[ACT]IVATED AML Resource Guide
January 31, 2023
Staying [ACT]IVATED AML Guide
How Does Health Policy Impact Me? Activity Guide
AML Patient Self-Advocacy Profiles
Jeanine’s AML Journey: Finding Your Voice After Diagnosis
January 21, 2026
30-Year Acute Myeloid Leukemia Survivor Shares His Journey
March 14, 2023
Advocacy Tips From an AML Patient
March 13, 2023
How I Overcame Biases During AML Treatment
March 13, 2023
What I Wish I Knew Before My AML Diagnosis
March 13, 2023
How Does One’s Culture Impact AML Care?
March 13, 2023
[ACT]IVATED AML is brought to you by Patient Empowerment Network. It is sponsored by AbbVie, Inc., Merck and through generous donations from people like you.